bioAffinity Technologies, Inc. (BIAF) — 分析师展望 / 分析师共识目标价为. 基于 1 位分析师评级, 共识为 中性 — 1 持有.
分析师预估 每股收益(EPS)为 $-20.70 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.73 vs 预期 $-20.70 (超预期 +96.5%). 2025: 实际 $-8.66 vs 预期 $-14.40 (超预期 +39.9%). 分析师准确度: 0%.
BIAF 分析师评级
Hold
基于过去3个月内 1 位分析师对 bioAffinity Technologies, Inc. 的评级
EPS 预测 — BIAF
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.73
vs Est –$20.70
▲ 2,735.6% off
2025
Actual –$8.66
vs Est –$14.40
▲ 66.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — BIAF
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.009B
vs Est $0.010B
▼ 2.2% off
2025
Actual $0.006B
vs Est $0.006B
▲ 1.2% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
